Clinical Trial Update: A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tigecycline to imipenem/cilastatin for complicated intra-abdominal infection; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infection

Drugs mentioned

• Primaxin (imipenem/cilastatin)
• TYGACIL (tigecycline)

Snippet

Sponsor: Pfizer | Conditions: Intra-abdominal Infection | Phase 4 | Status: COMPLETED | Results posted: 2018-04-09